Abstract

The Toxicology in the 21st Century (Tox21) project seeks to develop and test methods for high-throughput examination of the effect certain chemical compounds have on biological systems. Although primary and toxicity assay data were readily available for multiple reporter gene modified cell lines, extensive annotation and curation was required to improve these datasets with respect to how FAIR (Findable, Accessible, Interoperable, and Reusable) they are. In this study, we fully annotated the Tox21 published data with relevant and accepted controlled vocabularies. After removing unreliable data points, we aggregated the results and created three sets of signatures reflecting activity in the reporter gene assays, cytotoxicity, and selective reporter gene activity, respectively. We benchmarked these signatures using the chemical structures of the tested compounds and obtained generally high receiver operating characteristic (ROC) scores, suggesting good quality and utility of these signatures and the underlying data. We analyzed the results to identify promiscuous individual compounds and chemotypes for the three signature categories and interpreted the results to illustrate the utility and re-usability of the datasets. With this study, we aimed to demonstrate the importance of data standards in reporting screening results and high-quality annotations to enable re-use and interpretation of these data. To improve the data with respect to all FAIR criteria, all assay annotations, cleaned and aggregate datasets, and signatures were made available as standardized dataset packages (Aggregated Tox21 bioactivity data, 2019).

Highlights

  • The Toxicology in the 21st Century (Tox21) compound screening project is a collaborative effort by the National Institutes of Health (NIH), the Environmental Protection Agency (EPA), and the Food andDrug Administration (FDA) to develop and utilize new toxicity screening assays to examine potential detrimental effects to human health and biological processes [1,2,3,4]

  • Data produced through the Tox21 program and the compound library they built have been utilized for numerous predictive assays, including external examination of constitutive androstane receptor (CAR) [5], mitochondrial function [6,7], androgen receptor [8,9], and predictive data for in vivo toxicity and side effects in humans [10,11,12,13,14,15]

  • To improve FAIR principle compliance, all 68 assays were manually curated and annotated based on the BioAssay Ontology vocabulary for key factors associated with Findability, Interoperability, and Reusability

Read more

Summary

Introduction

The Toxicology in the 21st Century (Tox21) compound screening project is a collaborative effort by the National Institutes of Health (NIH), the Environmental Protection Agency (EPA), and the Food andDrug Administration (FDA) to develop and utilize new toxicity screening assays to examine potential detrimental effects to human health and biological processes [1,2,3,4]. Data produced through the Tox program and the compound library they built have been utilized for numerous predictive assays, including external examination of constitutive androstane receptor (CAR) [5], mitochondrial function [6,7], androgen receptor [8,9], and predictive data for in vivo toxicity and side effects in humans [10,11,12,13,14,15] While these data have been produced, used, and reused in varied forms, it remains left to the individual analysis personnel to determine the best course to aggregate and clean the published Tox datasets for statistical analysis and reuse, thereby potentially limiting its impact.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.